0921B |
Cadmium, Blood |
0921H |
Cadmium, Hair |
0921N |
Cadmium, Nails |
0921R |
Cadmium, RBCs |
0921SP |
Cadmium, Serum/Plasma |
0921TI |
Cadmium, Tissue |
0921U |
Cadmium, Urine |
0921UH |
Cadmium, 24 Hour Urine |
0938FL |
Calcium - Total, Postmortem, Fluid (Forensic) |
0938R |
Calcium - Total, RBCs |
0938U |
Calcium - Total, Urine |
0939B |
Calcium - Total, Postmortem, Blood (Forensic) |
0995U |
Carbon Disulfide Exposure (TTCA), Urine |
1010B |
Carbon Tetrachloride, Blood |
1042B |
Cesium, Blood |
1042SP |
Cesium, Serum/Plasma |
1042U |
Cesium, Urine |
1080B |
Chlordiazepoxide and Metabolite, Blood |
1080SP |
Chlordiazepoxide and Metabolite, Serum/Plasma |
1080U |
Chlordiazepoxide and Metabolite, Urine |
1110B |
Chlorobenzene, Blood |
1110SP |
Chlorobenzene, Serum/Plasma |
1111U |
Chlorobenzene Exposure (p-Chlorophenol), Urine |
1130B |
Chloroform, Blood |
1261B |
Chromium, Blood |
1261FL |
Chromium, Fluid |
1261H |
Chromium, Hair |
1261N |
Chromium, Nails |
1261R |
Chromium, RBCs |
1261SP |
Chromium, Serum/Plasma |
1261TI |
Chromium, Tissue |
1261U |
Chromium, Urine |
1265B |
Chromium and Cobalt, Blood |
1265SP |
Chromium and Cobalt, Serum/Plasma |
1265U |
Chromium and Cobalt, Urine |
1290B |
Cobalt, Blood |
1290FL |
Cobalt, Fluid |
1290H |
Cobalt, Hair |
1290N |
Cobalt, Nails |
1290R |
Cobalt, RBCs |
1290SP |
Cobalt, Serum/Plasma |
1290TI |
Cobalt, Tissue |
1290U |
Cobalt, Urine |
1290UH |
Cobalt, 24 Hour Urine |
1330B |
Copper, Blood |
1330FL |
Copper, Fluid |
1330H |
Copper, Hair |
1330R |
Copper, RBCs |
1330SP |
Copper, Serum/Plasma |
1330TI |
Copper, Tissue |
1330U |
Copper, Urine |
1333SP |
Copper - Free, Serum/Plasma |
2423B |
Comprehensive Volatiles Panel, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |